Efficacy and Safety of Administration of High Levels of Protein to Critically Ill Patients.

NAActive, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

March 31, 2024

Study Completion Date

June 30, 2024

Conditions
Intensive Care Unit Acquired Weakness
Interventions
OTHER

Protein dose 1.5 g/kg/day

Administration of 1.5 g of protein/kg/day via enteral/parenteral nutrition

OTHER

Protein dose 1.0 g/kg/day

Administration of 1.0 g of protein/kg/day via enteral/parenteral nutrition

Trial Locations (18)

12004

Hospital General Universitario de Castellón, Castellon

17007

Hospital Universitario Doctor Josep Trueta, Girona

18016

Hospital Universitario Clínico San Cecilio, Granada

22004

Hospital Universitario San Jorge, Huesca

22300

Hospital de Barbastro, Barbastro

28041

Hospital Universitario 12 de Octubre, Madrid

28046

Hospital Universitario La Paz, Madrid

28942

Hospital Universitario de Fuenlabrada, Fuenlabrada

28981

Hospital Universitario Infanta Cristina, Parla

29010

Hospital Universitario Regional de Málaga, Málaga

30008

Hospital General Universitario Morales Meseguer, Murcia

30120

Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar

30202

Hospital General Universitario Santa Lucía, Cartagena

30739

Hospital General Universitario Los Arcos del Mar Menor, Pozo-Aledo

08916

Hospital Universitario Germans Trias i Pujol, Badalona

08907

Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat

06080

Hospital Universitario de Badajoz, Badajoz

07500

Hospital de Manacor, Manacor

All Listed Sponsors
lead

Spanish Society of Critical Care Medicine and Coronary Units

OTHER